Sage, a leading independent academic publisher, has acquired Mary Ann Liebert, Inc., a renowned global media company publishing more than 100 peer-reviewed journals in biotechnology and the life sciences, specialized clinical medicine, public health and policy, and technology and engineering, as well as the leading B2B media brands Genetic Engineering & Biotechnology News (GEN) and Inside Precision Medicine.
“This acquisition marks the joining of two mission-driven publishers founded by women who are pioneers in academic publishing,” said Blaise Simqu, Sage CEO. “Mary Ann Liebert and I have been friends and publishing colleagues for 20 years, and I have worked side-by-side with Sara Miller McCune, Sage’s Founder, for more than 30 years. Both women are extraordinary. Both took big risks, invested their own resources, and created publishing houses that have enabled researchers to break new ground in emerging fields and ultimately, serve humanity. With a future at Sage – and with Sage’s independence guaranteed – Mary Ann Liebert, Inc. will continue in the entrepreneurial spirit that has steered both founders.”
Journals will continue to be published under the Mary Ann Liebert, Inc. name, and Sage will begin publishing a segment of Sage’s life sciences and medical journals under the Mary Ann Liebert, Inc. imprint.
“Our journals and media brands are exceptional and have years of growth ahead of them, which will now be enabled and accelerated by Sage,” said company founder Mary Ann Liebert. “Sage’s founder Sara Miller McCune and I are philosophically aligned – we have both created and published journals to advance their fields and produce better outcomes for humanity. We’ve both embedded a spirit of independence into our companies, allowing our talented staff to be creative and act swiftly when opportunities arise. Sage is the perfect home for Mary Ann Liebert, Inc. and I’m confident that scientists, librarians, and all members of the academic community will benefit.”
Since its launch in 1980, Mary Ann Liebert, Inc. has broken ground in new and emerging fields, identifying areas of need and dedicating resources to developing research in specialized areas such as genetic engineering and gene therapy, tissue engineering, patient care, endocrinology, health equity and disparities, and more. Mary Ann Liebert, Inc. launched the first publication in biotechnology, Genetic Engineering & Biotechnology News (GEN), which is now the leading media brand in the field, as well as peer-reviewed journals AIDS Research & Human Retroviruses during the height of the AIDS epidemic, the first-in-the-field The CRISPR Journal in 2018, and more recently, AI in Precision Oncology and AI in Neuroscience.
Today, Mary Ann Liebert, Inc. titles are ranked in the top of their fields such as Diabetes Technology & Therapeutics, a leading journal for medical laboratory technology, Autism in Adulthood, ranked first in both Development Psychology and Rehabilitation, and Advances in Wound Care, ranked second in emergency medicine. Mary Ann Liebert, Inc. likewise has a strong portfolio of educational multimedia content, including webinars, summits, podcasts, and eBooks.
“We are excited to embark on this new chapter with Sage, a publisher that aligns with our values and dedication to excellence in scientific and medical publishing,” said Marianne Russell, CEO of Mary Ann Liebert, Inc. “This acquisition will significantly enhance our reach and impact, ensuring the content we publish continues to make a difference in the world and that we can continue to support the global research community.”
“We’re thrilled to bring Mary Ann Liebert, Inc. to Sage for many reasons, chief among them the quality of their journals that are prominent in their fields and that publish science that is authoritative and impactful,” said Bob Howard, Executive Vice President of Research at Sage. “With this acquisition, we will honor and build upon Mary Ann Liebert’s legacy while growing the portfolio’s reach and impact.”
The transition of Mary Ann Liebert, Inc. to Sage will begin immediately, with a focus on maintaining high standards of publishing quality and customer service. Authors, editors, and readers can expect a seamless transition and continued access to the Mary Ann Liebert, Inc. journals throughout the process.
# # #
About Mary Ann Liebert, Inc.
Mary Ann Liebert, Inc. is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services to advance the fields of biotechnology and the life sciences, specialized clinical medicine, and public health and policy. For complete information, please visit the Mary Ann Liebert, Inc., website.
About Sage
Sage is a global academic publisher of books, journals, and library resources with a growing range of technologies to enable discovery, access, and engagement. Believing that research and education are critical in shaping society, 24-year-old Sara Miller McCune founded Sage in 1965. Today, we are controlled by a group of trustees charged with maintaining our independence and mission indefinitely.
Our guaranteed independence means we’re free to:
- Do more– supporting an equitable academic future, furthering disciplines that drive social change, and helping social and behavioral science make an impact
- Work together– building lasting relationships, championing diverse perspectives, and co-creating resources to transform teaching and learning
- Think long-term– experimenting, taking risks, and investing in new ideas